List details
Basic info
| Status | Opinion Adopted |
|---|---|
| Submitter | Norway |
| Regulatory programme |
|
| ATP number and date | ATP18 - (16/02/2022), 23/11/2023 |
| Link to ATP |
|
Classification
| Proposed harmonised classification by the dossier submitter |
|
|---|---|
| Hazard classes open for commenting | Germ cell mutagenicity Carcinogenicity Reproductive toxicity Specific target organ toxicity — repeated exposure |
Intention timeline
| Date of intention | 2018-08-20 |
|---|---|
| Expected date of submission | 2018-12-31 |
| Submitted for accordance check | 2018-12-19 |
| Final submission date | 2019-06-14 |
| Start of consultation | 2019-07-24 |
| Deadline for commenting | 2019-09-24 |
| Date of opinion | 2020-06-11 |
| Legal deadline for opinion adoption | 2020-12-13 |
Documents
| CLH report |
|
|---|---|
| Annexes to the CLH Report |
|
| Comments received |
|
| Public consultations - received attachments |
|
| RAC opinion |
|
| Background document |
|
Related substances
By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.
Related regulatory records
Record history
The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.
This version
Jan. 18, 2023
- ATP number and date: ATP18 - (16/02/2022), 23/11/2023
- Link to ATP / File Title: Official Journal
- Link to ATP / Full Path: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32022R0692&qid=1667995782196
Jan. 19, 2021
- Annexes to the CLH Report: https://echa.europa.eu/documents/10162/17172a2c-7a31-cff9-c212-7066b587f253
- CLH report: https://echa.europa.eu/documents/10162/97640cd4-565c-bddd-dac2-95af503b12eb
- Public consultations - received attachments: https://echa.europa.eu/documents/10162/78585fed-9339-4cbc-4a4b-4b080b890a74
Dec. 22, 2020
- Background document: https://echa.europa.eu/documents/10162/bd0b8996-d515-ee8b-e436-56dd18d7194a
- Comments received: https://echa.europa.eu/documents/10162/c4f4469c-077f-c584-ccec-325eb199d888
Dec. 14, 2020
- Comments received: https://echa.europa.eu/documents/10162/0e942393-9a0c-9ff8-c908-6f5c76d27657
- RAC opinion: https://echa.europa.eu/documents/10162/1040019b-b10a-7dc2-3ce7-e7da78c944c4
Dec. 7, 2020
- Annexes to the CLH Report: https://echa.europa.eu/documents/10162/57feb37a-0b58-b5fa-df9c-14df899e5ca9
- Background document: https://echa.europa.eu/documents/10162/30a91033-f169-aa0c-22a6-924d2c5bfcbc
- CLH report: https://echa.europa.eu/documents/10162/4b747f01-3396-771c-2219-98a6c7e14e91
- Comments received: https://echa.europa.eu/documents/10162/7981e864-e91f-c67f-2dda-d819e5938766 → https://echa.europa.eu/documents/10162/0e942393-9a0c-9ff8-c908-6f5c76d27657
- Public consultations - received attachments: https://echa.europa.eu/documents/10162/efabb20d-17e8-7cff-01c6-2edb6955bff8
- RAC opinion: https://echa.europa.eu/documents/10162/58cd20c5-9926-9899-bdd6-3adbffa92fd5 → https://echa.europa.eu/documents/10162/1040019b-b10a-7dc2-3ce7-e7da78c944c4
- RAC opinion: https://echa.europa.eu/documents/10162/aeb7c6a7-9f6a-7bf3-3f33-be6c40aab0fe
Oct. 27, 2020
- RAC opinion: https://echa.europa.eu/documents/10162/306b4a45-d5a1-f6bb-d2eb-af001bf4b850 → https://echa.europa.eu/documents/10162/58cd20c5-9926-9899-bdd6-3adbffa92fd5
Sept. 25, 2020
- Background document: https://echa.europa.eu/documents/10162/30a91033-f169-aa0c-22a6-924d2c5bfcbc
- Comments received: https://echa.europa.eu/documents/10162/5bd43ec3-e7b5-24d3-b1eb-f0b27898fb18 → https://echa.europa.eu/documents/10162/7981e864-e91f-c67f-2dda-d819e5938766
- Date of opinion: 2020-06-12 → 2020-06-11
- RAC opinion: https://echa.europa.eu/documents/10162/306b4a45-d5a1-f6bb-d2eb-af001bf4b850
July 14, 2020
- Date of opinion: 2020-06-12
- Status: Opinion Development → Opinion Adopted
May 14, 2020
- Name: 2,2-dimethylpropan-1-ol, tribromo derivative → 2,2-dimethylpropan-1-ol, tribromo derivative; 3-bromo-2,2-bis(bromomethyl)propan-1-ol
Oct. 8, 2019
- Comments received: https://echa.europa.eu/documents/10162/5bd43ec3-e7b5-24d3-b1eb-f0b27898fb18
- Public consultations - received attachments: https://echa.europa.eu/documents/10162/efabb20d-17e8-7cff-01c6-2edb6955bff8
Oct. 1, 2019
- Status: Public Consultation → Opinion Development
July 29, 2019
- Annexes to the CLH Report: https://echa.europa.eu/documents/10162/57feb37a-0b58-b5fa-df9c-14df899e5ca9
- CLH report: https://echa.europa.eu/documents/10162/4b747f01-3396-771c-2219-98a6c7e14e91
- Deadline for commenting: 2019-09-24
- Final submission date: 2019-06-14
- Hazard classes open for commenting: Germ cell mutagenicity Carcinogenicity Reproductive toxicity Specific target organ toxicity — repeated exposure
- Legal deadline for opinion adoption: 2020-12-13
- Status: Submitted → Public Consultation
- Start of consultation: 2019-07-24
May 14, 2019
- Submitter: Norway
May 7, 2019
- Submitter: Norway
April 4, 2019
- Regulatory programme: Other substance → Chemical registered under REACH
- Remarks: read-across to EC 221-967-7 (BMP)
Jan. 8, 2019
- Status: Intention → Submitted
- Submitted for accordance check: 2018-12-19
Add the related substance to your watchlist to monitor this regulatory record.